10 Bladder Cancer Clinical Trials in Baltimore, MD (2026)

Q: How do I join a clinical trial in Baltimore?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you.

Recruiting Bladder Cancer Studies in Baltimore

NCT03193970Recruiting

Measuring Surgical Recovery After Radical Cystectomy

The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of th...

Baltimore, MD2,000 participantsM.D. Anderson Cancer Center

View Study Details

NCT05874921Recruiting

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

The purpose of this registry is to evaluate real world experience and outcomes of patients with Upper Tract Urothelial Cancer (UTUC) treated with Jelmyto in the United States....

Baltimore, MD400 participantsUroGen Pharma Ltd.

View Study Details

NCT06525571Recruiting

Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

Comparing white-light cystoscopy (WLC) and blue-light cystoscopy (BLC) in TURBT for high risk (HR) non-muscle invasive bladder cancer (NMIBC) patients is crucial to determine the most effective method...

Baltimore, MDPHASE3200 participantsJohns Hopkins University

View Study Details

NCT07225205Recruiting

Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy

Radical cystectomy is the standard of care for muscle invasive bladder cancer, however despite advances, it is still associated with high morbidity. Many complications may be driven by dehydration and...

Baltimore, MDNA130 participantsJohns Hopkins University

View Study Details

NCT06929286Recruiting

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

The purpose of this study is to compare the effectiveness of different FDA-approved/NCCN-recommended drug treatments for NMIBC. In particular, the FDA-approved drug nadofaragene firadenovec will be co...

Baltimore, MDPHASE3125 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05649306Recruiting

Gender Related Coping and Survivorship for Genitourinary Cancers

This research is being done to learn more about coping and survivorship of women with bladder cancer, specifically regarding psychosocial distress and sexual dysfunction. This study is a non-therapeut...

Baltimore, MD80 participantsJohns Hopkins University

View Study Details

NCT05792722Recruiting

Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy

The purpose of this clinical trial is to determine if prostate-capsule-sparing cystectomy improves functional outcomes without comprising oncologic outcomes in male patients receiving a radical cystec...

Baltimore, MDNA70 participantsJohns Hopkins University

View Study Details

NCT05312671Recruiting

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

This is a single arm, Phase II trial involving the use of atezolizumab plus platinum and etoposide for patients with locally advanced urothelial cancer. The primary goal of this trial is to assess the...

Baltimore, MDPHASE263 participantsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

View Study Details

NCT06637423Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

The goal of the study is to learn about the safety of Sacituzumab Tirumotecan and if people can tolerate it when given in the bladder and find the highest dose that people can take without having cert...

Baltimore, MDPHASE132 participantsMerck Sharp & Dohme LLC

View Study Details

NCT05656235Recruiting

Renal Retention in High Grade Upper Tract Urothelial Cancer

This trial will evaluate the use of combination pembrolizumab and enfortumab vedotin for patients with high grade non-metastatic (cN0/NxMx, no measurable regional lymph nodes, no metastases) upper tra...

Baltimore, MDPHASE220 participantsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

View Study Details

About Bladder Cancer Clinical Trials in Baltimore

Bladder cancer occurs in the tissues of the bladder and is one of the most common cancers. It has a high recurrence rate, requiring ongoing monitoring. Treatments include surgery, intravesical therapy, chemotherapy, and immunotherapy.

There are currently 10 bladder cancer clinical trials recruiting participants in Baltimore, MD. These studies are seeking a combined 3,120 participants. Research is being sponsored by M.D. Anderson Cancer Center, UroGen Pharma Ltd., Johns Hopkins University and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Bladder Cancer Clinical Trials in Baltimore — FAQ

Are there bladder cancer clinical trials in Baltimore?

Yes, there are 10 bladder cancer clinical trials currently recruiting in Baltimore, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Baltimore?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.

Are clinical trials in Baltimore free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.

What bladder cancer treatments are being tested?

The 10 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for bladder cancer.

Data updated July 18, 2026 from ClinicalTrials.gov